Found: 4
Select item for more details and to access through your institution.
Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na<sup>+</sup>/H<sup>+</sup> exchanger, lowering of cytosolic Na<sup>+</sup> and vasodilation.
- Published in:
- Diabetologia, 2018, v. 61, n. 3, p. 722, doi. 10.1007/s00125-017-4509-7
- By:
- Publication type:
- Article
Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells.
- Published in:
- Frontiers in Physiology, 2023, p. 01, doi. 10.3389/fphys.2023.1179131
- By:
- Publication type:
- Article
Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 14, p. 2699, doi. 10.1093/cvr/cvab129
- By:
- Publication type:
- Article
Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients.
- Published in:
- Frontiers in Physiology, 2018, p. N.PAG, doi. 10.3389/fphys.2018.01575
- By:
- Publication type:
- Article